Mycophenolic acid is a drug with the potential to be repurposed for suppressing tumor growth and metastasis in osteosarcoma treatment
© 2019 UICC Our previous review of proteomics data showed that in osteosarcoma, some overexpressed proteins were targets of FDA-approved immunosuppressive and anti-arrhythmic drugs, including mycophenolate mofetil (MMF), ribavirin, leflunomide, azathioprine and digoxin. Here, these drugs were screen...
Saved in:
Main Authors: | Jeerawan Klangjorhor, Parunya Chaiyawat, Pimpisa Teeyakasem, Nutnicha Sirikaew, Areerak Phanphaisarn, Jongkolnee Settakorn, Kriengsak Lirdprapamongkol, Sarawoot Yama, Jisnuson Svasti, Dumnoensun Pruksakorn |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85074795003&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/67630 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Expression profiling of DNA methyl transferase I (DNMT1) and efficacy of a DNA-hypomethylating agent (decitabine) in combination with chemotherapy in osteosarcoma
by: Parunya Chaiyawat, et al.
Published: (2020) -
Expression patterns of class i histone deacetylases in osteosarcoma: A novel prognostic marker with potential therapeutic implications
by: Parunya Chaiyawat, et al.
Published: (2018) -
Oncogenic roles of serine–threonine kinase receptor-associated protein (STRAP) in osteosarcoma
by: Dumnoensun Pruksakorn, et al.
Published: (2018) -
Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma
by: Parunya Chaiyawat, et al.
Published: (2018) -
Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma
by: Parunya Chaiyawat, et al.
Published: (2018)